3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
79
Breast Neoplasms
7
Neoplasms
6
Prostate Adenocarcinoma
2
Polycystic Ovary Syndrome
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Leiomyoma
2
Hodgkin Disease
2
Uveal Melanoma
1
Urogenital Neoplasms
1
Sleep Apnea, Obstructive
1
Skin Neoplasms
1
Recurrence
1
Prostatic Diseases
1
Premenopausal Breast Cancer
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
PSA Level Greater Than Two
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Neoplasms, Glandular and Epithelial
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Metabolic Syndrome
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphatic Metastasis
1
Lower Urinary Tract Symptoms
1
Leukemia, Myelomonocytic, Chronic
1
Interventions
mirabegron
1
Leuprolide
1
Doxazosin
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Lower Urinary Tract Symptoms
×
Leuprolide
×
Clear all
NCT01078545
2012-01-16
LEMON
Abbott
Completed
729 enrolled
14 charts